• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Cardiology

Higher cardiovascular mortality in low- and middle-income countries [PURE study]

August 28, 2014
in Cardiology, Chronic Disease, Public Health
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. Although the burden of cardiovascular risk factors was highest in high-income countries, the rate of major cardiovascular events was significantly greater in low- and middle-income countries. 

2. This is likely due to greater access to preventive therapies and control of risk factors in high-income countries. 

Evidence Rating Level: 2 (Good)

Study Rundown: The Prospective Urban Rural Epidemiologic (PURE) study investigated the global burden of noncommunicable diseases and involved over 150,000 participants from 17 low-, middle-, and high-income countries. Findings from the study on cardiovascular risk and the incidence of cardiovascular events were published in this article. The study found that the burden of cardiovascular risk factors was highest in high-income countries yet the rate of major cardiovascular events was lowest in these countries. Meanwhile, the rate of non-major cardiovascular events was highest in high-income countries. This trend could be explained by greater access to preventive therapies and higher educational levels in high-income countries. A strength of the study is the inclusion of both urban and rural communities as well as countries of varied socioeconomic levels. Limitations of the study include lower follow-up rates in urban communities of low-income countries and limited detection of events in low-income countries compared to high-income countries due to differences in access to health care facilities.

Click to read the study, published today in NEJM

Relevant Reading: Estimating modifiable coronary heart disease risk in multiple regions of the world: the INTERHEART modifiable risk score

RELATED REPORTS

Merck’s Winrevair: Pulmonary arterial hypertension drug shows success ahead of schedule

Novo Nordisk’s Rybelsus demonstrates reduction in cardiovascular events for patients with Type 2 diabetes and cardiovascular disease

High cardiovascular disease mortality among Native Hawaiian and Pacific Islander adults

In-Depth [prospective cohort]: This study included 156,424 adults from 628 urban and rural communities in 17 countries. Data was collected on major cardiovascular events (death from cardiovascular causes and nonfatal stroke, myocardial infarction, and heart failure) and nonmajor cardiovascular events (all other cardiovascular events that led to hospitalization). Risk-factor burden was calculated using the validated INTERHEART Risk Score. A score of 0 to 48 was assigned with higher scores indicating greater burden.

The high-income countries recorded the highest mean INTERHEART Risk Score of 12.89 compared to middle- and low-income countries which had mean scores of 10.47 and 8.28, respectively (P<0.001). The use of antiplatelet drugs was highest in high-income countries, intermediate in middle-income countries, and lowest in low-income countries. The same pattern held true for the use of beta-blockers, renin-angiotensin system blockers, statins, and coronary revascularization. Over a mean follow-up of 4.1 years, there were 3900 deaths. The rate of major cardiovascular events was lowest in high-income countries, intermediate in middle-income countries, and highest in low-income countries (P<0.001). This pattern was reversed for the rate of nonmajor cardiovascular events with the highest rate occurring in high-income countries and the lowest rate in low-income countries (P<0.001).

Image: PD

©2012-2014 2minutemedicine.com. All rights reserved. No works may be reproduced without expressed written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors, editors, staff or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT. 

Tags: cardiovascular disease
Previous Post

Low transmission in household contacts of patients with MERS-CoV

Next Post

Collaborative care model reduces depression in lung cancer patients [SMaRT Oncology-3 Trial]

RelatedReports

Pulmonary MRI with ultrashort echo time is comparable to pulmonary CT
Pharma

Merck’s Winrevair: Pulmonary arterial hypertension drug shows success ahead of schedule

March 25, 2025
Type 2 diabetes associated with reduction in disability-free life years
Pharma

Novo Nordisk’s Rybelsus demonstrates reduction in cardiovascular events for patients with Type 2 diabetes and cardiovascular disease

December 2, 2024
Successful regional implementation of pediatric chest pain algorithm
Cardiology

High cardiovascular disease mortality among Native Hawaiian and Pacific Islander adults

October 16, 2024
#VisualAbstract Edoxaban Monotherapy has Lower Risks for Atrial Fibrillation and Stable Coronary Artery Disease than Dual Antithrombotics
StudyGraphics

#VisualAbstract Edoxaban Monotherapy has Lower Risks for Atrial Fibrillation and Stable Coronary Artery Disease than Dual Antithrombotics

September 10, 2024
Next Post
Macitentan better than placebo for preventing progression of pulmonary arterial hypertension [SERAPHIN Trial]

Collaborative care model reduces depression in lung cancer patients [SMaRT Oncology-3 Trial]

High dose antidepressants may increase self-harm risk among children, young adults

Most cancer patients may not receive adequate treatment for comorbid depression

Damage similar in each eye after sequential ischemic optic neuropathy

Damage similar in each eye after sequential ischemic optic neuropathy

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Time-restricted eating does not confer changes in sleep, mood, or quality of life
  • Commonly cited medication triggers may not increase risk of microscopic colitis among older adults
  • Ablation may reduce stroke risk, death, heart failure hospitalization in patients with atrial fibrillation
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.